Since CCTA is not invasive and offers a good diagnostic performance [20,21], the integrated analysis of plaque load changes and DNA methylation signatures affecting HLA-G gene regulation may represent a useful approach to improve risk stratification for CHD patients. Here, HLA-G is linked to coronary artery disorder.